Imeglimin in Metformin-Intolerant Patients with Type 2 Diabetes: A Clinical Advancement for Real-World Challenges

Clinical Diabetology is a bimonthly, open access journal of scientific and educational profile, which was created by combining the scientific assumptions of Experimental and Clinical Diabetology (Diabetologia Doświadczalna i Kliniczna)

Authors

Vipul Chavda

Institutions

Institute of Medical Sciences (IN)

Publication Details

Journal: Clinical Diabetology
Published: 2025-06-30
DOI: https://doi.org/10.5603/cd.106925
Citations: 1
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 1.29

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Imeglimin in Metformin-Intolerant Patients with Type 2 Diabetes: A Clinical Advancement for Real-World Challenges

Vipul Chavda

Jun 30, 2025

1 citations

Clinical Diabetology

Diabetes Treatment and Management

1.29

article

Imeglimin in Metformin-Intolerant Patients with Type 2 Diabetes: A Clinical Advancement for Real-World Challenges

Vipul Chavda

June 30, 2025article en

1 citations

Abstract

Clinical DiabetologyVol. 14(3)

Institute of Medical Sciences (IN)

Openalex Percentile: Top 18%

Diabetes Treatment and Management

1.29

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Imeglimin in Metformin-Intolerant Patients with Type 2 Diabetes: A Clinical Advancement for Real-World Challenges — Vipul Chavda · Clinical Diabetology (2025) | TGRS Research Map | TGRS